Gibbs Lab

Our specific research interests include:

• Tumour biomarker research to predict cancer behaviour
• Blood biomarker research, including prospective randomised trials, to better define risk of recurrence after surgery and to improve treatment selection
• Laboratory models, including testing miniature cancers derived from patient biopsies, to predict response to treatment
• Collecting comprehensive patient, treatment and outcome data to better measure quality and to identify opportunities for improved cancer treatment
• Registry based clinical trials to improve and optimise use of available therapies
• Interventional Clinical Trials partnering with cooperative groups such as the AGITG and others looking at interventional therapies and providing all aspects of clinical trials management.

The Gibbs Lab team strive to positively impact the outcomes for all patients through its work in data registries, registry trials, blood biomarkers, organoids development, clinical trials and quality tools, translating basic research into clinical applications that can better serve cancer patients.